TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 Asia Pacific T Cell Therapy Market, by Country (US$ Million)
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific T Cell Therapy Market - Key Industry Dynamics
4.1 Market Drivers:
4.1.1 Growing Burden of Cancer Worldwide
4.1.2 Increasing Number of T-Cell Therapy Approvals
4.2 Market Restraints
4.2.1 Side-effects of CAR T-Cell Therapy
4.3 Market Opportunities
4.3.1 Growing Investment in T-Cell Therapy
4.4 Future Trends
4.4.1 Rising Number of CAR T-Cell Therapies in Clinical Trials
4.5 Impact Analysis:
5. T Cell Therapy Market - Asia Pacific Market Analysis
5.1 Asia Pacific T Cell Therapy Market Revenue (US$ Mn), 2022 - 2030
6. Asia Pacific T Cell Therapy Market - Revenue and Forecast to 2030 - by Modality.
6.1 Overview
6.2 Asia Pacific T Cell Therapy Market Revenue Share, by Modality, 2022 & 2030 (%)
6.3 Research
6.3.1 Overview
6.3.2 Research: Asia Pacific T Cell Therapy Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Commercialized
6.4.1 Overview
6.4.2 Commercialized: Asia Pacific T Cell Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7. Asia Pacific T Cell Therapy Market - Revenue and Forecast to 2030 - by Therapy Type
7.1 Overview
7.2 Asia Pacific T Cell Therapy Market Revenue Share, by Therapy Type 2022 & 2030 (%)
7.3 CAR T-cell Therapy
7.3.1 Overview
7.3.2 CAR T-cell Therapy: Asia Pacific T Cell Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.4 T-cell Receptor (TCR)-based.
7.4.1 Overview
7.4.2 T-cell Receptor (TCR)-based: Asia Pacific T Cell Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8. Asia Pacific T Cell Therapy Market - Revenue and Forecast to 2030 - by Indication.
8.1 Overview
8.2 Asia Pacific T Cell Therapy Market Revenue Share, by Indication, 2022 & 2030 (%)
8.3 Hematologic Malignancies
8.3.1 Overview
8.3.2 Hematologic Malignancies: Asia Pacific T Cell Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.3.3 Asia Pacific T Cell Therapy Market, by Haematological Malignancies, 2020-2030 (US$ Million)
8.4 Solid Tumor
8.4.1 Overview
8.4.2 Solid Tumor: Asia Pacific T Cell Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9. Asia Pacific T Cell Therapy Market - Country Analysis
9.1 Overview
9.1.1.1 Asia Pacific T Cell Therapy Market, by Country
9.1.1.2 China
9.1.1.2.1 China: Asia Pacific T Cell Therapy Market Revenue and Forecast to 2030 (US$ Mn)
9.1.1.2.2 China: Asia Pacific T Cell Therapy Market, by Modality, 2020-2030 (US$ Million)
9.1.1.2.3 China: Asia Pacific T Cell Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
9.1.1.2.4 China: Asia Pacific T Cell Therapy Market, by Indication, 2020-2030 (US$ Million)
9.1.1.2.4.1 China: Asia Pacific T Cell Therapy Market, For Hematologic Malignancies by Indication, 2020-2030 (US$ Million)
9.1.1.3 Japan
9.1.1.3.1 Japan: Asia Pacific T Cell Therapy Market Revenue and Forecast to 2030 (US$ Mn)
9.1.1.3.2 Japan: Asia Pacific T Cell Therapy Market, by Modality, 2020-2030 (US$ Million)
9.1.1.3.3 Japan: Asia Pacific T Cell Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
9.1.1.3.4 Japan: Asia Pacific T Cell Therapy Market, by Indication, 2020-2030 (US$ Million)
9.1.1.3.4.1 Japan: Asia Pacific T Cell Therapy Market, For Hematologic Malignancies by Indication, 2020-2030 (US$ Million)
9.1.1.4 Australia
9.1.1.4.1 Australia: Asia Pacific T Cell Therapy Market Revenue and Forecast to 2030 (US$ Mn)
9.1.1.4.2 Australia: Asia Pacific T Cell Therapy Market, by Modality, 2020-2030 (US$ Million)
9.1.1.4.3 Australia: Asia Pacific T Cell Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
9.1.1.4.4 Australia: Asia Pacific T Cell Therapy Market, by Indication, 2020-2030 (US$ Million)
9.1.1.4.4.1 Australia: Asia Pacific T Cell Therapy Market, For Hematologic Malignancies by Indication, 2020-2030 (US$ Million)
9.1.1.5 South Korea
9.1.1.5.1 South Korea: Asia Pacific T Cell Therapy Market Revenue and Forecast to 2030 (US$ Mn)
9.1.1.5.2 South Korea: Asia Pacific T Cell Therapy Market, by Modality, 2020-2030 (US$ Million)
9.1.1.5.3 South Korea: Asia Pacific T Cell Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
9.1.1.5.4 South Korea: Asia Pacific T Cell Therapy Market, by Indication, 2020-2030 (US$ Million)
9.1.1.5.4.1 South Korea: Asia Pacific T Cell Therapy Market, For Hematologic Malignancies by Indication, 2020-2030 (US$ Million)
9.1.1.6 Rest of Asia Pacific
9.1.1.6.1 Rest of Asia Pacific: Asia Pacific T Cell Therapy Market Revenue and Forecast to 2030 (US$ Mn)
9.1.1.6.2 Rest of Asia Pacific: Asia Pacific T Cell Therapy Market, by Modality, 2020-2030 (US$ Million)
9.1.1.6.3 Rest of Asia Pacific: Asia Pacific T Cell Therapy Market, by Therapy Type, 2020-2030 (US$ Million)
9.1.1.6.4 Rest of Asia Pacific: Asia Pacific T Cell Therapy Market, by Indication, 2020-2030 (US$ Million)
9.1.1.6.4.1 Rest of Asia Pacific: Asia Pacific T Cell Therapy Market, For Hematologic Malignancies by Indication, 2020-2030 (US$ Million)
10. T Cell Therapy Market-Industry Landscape
10.1 Overview
10.2 Growth Strategies in T Cell Therapy Market
10.3 Organic Growth Strategies
10.3.1 Overview
10.4 Inorganic Growth Strategies
10.4.1 Overview
11. Company Profiles
11.1 Legend Biotech Corp
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Janssen Global Services LLC
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Gilead Sciences Inc
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Bristol-Myers Squibb Co
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Novartis AG
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 JW (Cayman) Therapeutics Co Ltd
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Innovent Biologics Inc
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
12. Appendix
12.1 About Us
12.2 Glossary of Terms



List of Tables
Table 1. Asia Pacific T Cell Therapy Market Segmentation
Table 2. Asia Pacific T Cell Therapy Market, by Hematological Malignancies - Revenue and Forecast to 2030 (US$ Million)
Table 3. FDA-Approved Autologous CAR T-Cell Therapies Registered in Asia Pacific
Table 4. China: Asia Pacific T Cell Therapy Market, by Modality - Revenue and Forecast to 2030 (US$ Million)
Table 5. China: Asia Pacific T Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 6. China: Asia Pacific T Cell Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 7. China: Asia Pacific T Cell Therapy Market, For Hematologic Malignancies by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 8. Japan: Asia Pacific T Cell Therapy Market, by Modality - Revenue and Forecast to 2030 (US$ Million)
Table 9. Japan: Asia Pacific T Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 10. Japan: Asia Pacific T Cell Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 11. Japan: Asia Pacific T Cell Therapy Market, For Hematologic Malignancies by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 12. Australia: Asia Pacific T Cell Therapy Market, by Modality - Revenue and Forecast to 2030 (US$ Million)
Table 13. Australia: Asia Pacific T Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 14. Australia: Asia Pacific T Cell Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 15. Australia: Asia Pacific T Cell Therapy Market, For Hematologic Malignancies by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 16. South Korea: Asia Pacific T Cell Therapy Market, by Modality - Revenue and Forecast to 2030 (US$ Million)
Table 17. South Korea: Asia Pacific T Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 18. South Korea: Asia Pacific T Cell Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 19. South Korea: Asia Pacific T Cell Therapy Market, For Hematologic Malignancies by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 20. Rest of Asia Pacific: Asia Pacific T Cell Therapy Market, by Modality - Revenue and Forecast to 2030 (US$ Million)
Table 21. Rest of Asia Pacific: Asia Pacific T Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)
Table 22. Rest of Asia Pacific: Asia Pacific T Cell Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 23. Rest of Asia Pacific: Asia Pacific T Cell Therapy Market, For Hematologic Malignancies by Indication - Revenue and Forecast to 2030 (US$ Million)
Table 24. Recent Organic Growth Strategies in Asia Pacific T Cell Therapy Market
Table 25. Recent Inorganic Growth Strategies in the Asia Pacific T Cell Therapy Market
Table 26. Glossary of Terms, Asia Pacific T Cell Therapy Market

List of Figures
Figure 1. Asia Pacific T Cell Therapy Market Segmentation, By Country
Figure 2. Asia Pacific T Cell Therapy Market - Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Asia Pacific T Cell Therapy Market Revenue (US$ Mn), 2022 - 2030
Figure 5. Asia Pacific T Cell Therapy Market Revenue Share, by Modality, 2022 & 2030 (%)
Figure 6. Research: Asia Pacific T Cell Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Commercialized: Asia Pacific T Cell Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Asia Pacific T Cell Therapy Market Revenue Share, by Therapy Type 2022 & 2030 (%)
Figure 9. CAR T-cell Therapy: Asia Pacific T Cell Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. T-cell Receptor (TCR)-based: Asia Pacific T Cell Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Asia Pacific T Cell Therapy Market Revenue Share, by Indication, 2022 & 2030 (%)
Figure 12. Hematologic Malignancies: Asia Pacific T Cell Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Solid Tumor: Asia Pacific T Cell Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Asia Pacific T Cell Therapy Market, by Key Country - Revenue, 2022 (US$ Million)
Figure 15. Asia Pacific T Cell Therapy Market, By Key Countries, 2022 and 2030 (%)
Figure 16. China: Asia Pacific T Cell Therapy Market Revenue and Forecast to 2030 (US$ Mn)
Figure 17. Japan: Asia Pacific T Cell Therapy Market Revenue and Forecast to 2030 (US$ Mn)
Figure 18. Australia: Asia Pacific T Cell Therapy Market Revenue and Forecast to 2030 (US$ Mn)
Figure 19. South Korea: Asia Pacific T Cell Therapy Market Revenue and Forecast to 2030 (US$ Mn)
Figure 20. Rest of Asia Pacific: Asia Pacific T Cell Therapy Market Revenue and Forecast to 2030 (US$ Mn)
Figure 21. Growth Strategies in T Cell Therapy Market

CONTACT US

If you have any queries about this report or would like further information, please contact us:

US: +1-646-491-9876
Asia-Pacific: +91-20-69018686
UK: +44-20-8125-4005
Email: sales@theinsightpartners.com




DISCLAIMER

All Rights Reserved.

No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form by any means, electronic, mechanical, photocopying, recording or otherwise without the prior permission of the publisher, \"The Insight Partners\".